Posterior Reversible Encephalopathy Syndrome as an Adverse Effect of Lenvatinib in a Patient with Papillary Thyroid Carcinoma: A Case Report

Posterior reversible encephalopathy syndrome (PRES) is an uncommon transient neuroradiological phenomenon that develops vasogenic cerebral edema and could be caused by some pharmacological agents, such as molecular-specific target agents. Lenvatinib belongs to the tyrosine kinase inhibitors and was...

Descripción completa

Detalles Bibliográficos
Autores principales: Buenaventura, Daisy Carolina, Vargas-Sierra, Hernando, Aristizabal-Henao, Natalia, Torres-Grajales, Jose Luis, Aguilar-Londono, Carolina, Gutierrez-Restrepo, Johnayro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Brieflands 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10676670/
https://www.ncbi.nlm.nih.gov/pubmed/38028246
http://dx.doi.org/10.5812/ijem-136900

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10676670/
https://www.ncbi.nlm.nih.gov/pubmed/38028246
http://dx.doi.org/10.5812/ijem-136900

Ejemplares similares